Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Chubb
Argus Health
Julphar
Mallinckrodt
Covington
AstraZeneca
Accenture
Cipla
US Department of Justice

Generated: February 19, 2018

DrugPatentWatch Database Preview

Fluocinonide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for fluocinonide and what is the scope of fluocinonide patent protection?

Fluocinonide
is the generic ingredient in five branded drugs marketed by Fougera Pharms Inc, G And W Labs Inc, Glenmark Generics, Perrigo Israel, Perrigo New York, Taro, Teva, Fougera Pharms, Cnty Line Pharms, Medicis, Novel Labs Inc, and Teva Pharms, and is included in thirty-three NDAs. There are four patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Fluocinonide has eleven patent family members in nine countries.

There are nine drug master file entries for fluocinonide. Thirty-one suppliers are listed for this compound.
Summary for fluocinonide
Pharmacology for fluocinonide
Medical Subject Heading (MeSH) Categories for fluocinonide

US Patents and Regulatory Information for fluocinonide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms FLUOCINONIDE fluocinonide OINTMENT;TOPICAL 074905-001 Aug 26, 1997 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Taro FLUOCINONIDE fluocinonide CREAM;TOPICAL 019117-001 Jun 26, 1984 AB1 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva FLUOCINONIDE fluocinonide SOLUTION;TOPICAL 072511-001 Feb 7, 1989 AT RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Medicis VANOS fluocinonide CREAM;TOPICAL 021758-001 Feb 11, 2005 AB RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Taro FLUOCINONIDE fluocinonide CREAM;TOPICAL 200734-001 Jul 14, 2014 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Fougera Pharms Inc FLUOCINONIDE fluocinonide SOLUTION;TOPICAL 072934-001 Feb 27, 1995 AT RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Cnty Line Pharms FLUOCINONIDE fluocinonide GEL;TOPICAL 017373-001 Approved Prior to Jan 1, 1982 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
G And W Labs Inc FLUOCINONIDE EMULSIFIED BASE fluocinonide CREAM;TOPICAL 074204-001 Jun 13, 1995 AB2 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
G And W Labs Inc FLUOCINONIDE fluocinonide CREAM;TOPICAL 073085-001 Feb 14, 1992 AB1 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Cnty Line Pharms LIDEX fluocinonide SOLUTION;TOPICAL 018849-001 Apr 6, 1984 AT RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for fluocinonide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Cnty Line Pharms LIDEX fluocinonide CREAM;TOPICAL 016908-002 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Cnty Line Pharms LIDEX fluocinonide CREAM;TOPICAL 016908-002 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Cnty Line Pharms LIDEX fluocinonide OINTMENT;TOPICAL 016909-002 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for fluocinonide

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,217,422 Compositions and methods for enhancing corticosteroid delivery ➤ Sign Up
7,771,733 Compositions and methods for enhancing corticosteroid delivery ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for fluocinonide

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
McKinsey
Medtronic
Cantor Fitzgerald
Chubb
UBS
Accenture
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot